We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Spire Healthcare Group Plc | LSE:SPI | London | Ordinary Share | GB00BNLPYF73 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.50 | -0.20% | 246.50 | 246.00 | 247.00 | 247.00 | 246.50 | 247.00 | 24,565 | 08:15:58 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Health & Allied Services,nec | 1.36B | 27.3M | 0.0676 | 36.54 | 998.2M |
From Apr 2019 to Apr 2024
TIDMSPI
RNS Number : 9742W
JPMorgan Securities Plc
20 November 2017
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-
SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Name of exempt principal trader: J.P. Morgan Securities Plc ---------------------------------------------------------- ---------------------------------------------------------- (b) Name of offeror/offeree in relation to whose relevant Spire Healthcare Group plc securities this form relates: Use a separate form for each offeror/offeree ---------------------------------------------------------- ---------------------------------------------------------- (c) Name of the party to the offer with which exempt Corporate Broker & Financial Advisor to Spire Healthcare principal trader is connected: Group plc ---------------------------------------------------------- ---------------------------------------------------------- (d) Date dealing undertaken: 17 November 2017 ---------------------------------------------------------- ---------------------------------------------------------- (e) In addition to the company in 1(b) above, is the Yes exempt principal trader making disclosures Mediclinic International plc in respect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A" ---------------------------------------------------------- ---------------------------------------------------------- 2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
Hot Features
Premium
(a) Purchases and sales
Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
(GBP) (GBP)
----------------------- ----------------- ------------------------ ----------------------- -----------------------
Ordinary Shares Purchases 47,781 2.7460 2.6814
Sales 374,154 2.7460 2.6600
----------------------- ----------------- ------------------------ ----------------------- -----------------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities (GBP)
long/short position,
increasing/reducing a
long/short position
------------------------- -------------------- ------------------------- ------------------------- ---------------
Ordinary Shares Equity Swaps Long 3,462 2.6768
290,000 2.6874
97 2.6968
9,635 2.6969
25,378 2.7034
13,486 2.7085
13 2.7097
11,108 2.7098
1,623 2.7123
1,027 2.7124
13,123 2.7231
1,176 2.7250
1,248 2.7350
Short 265 2.6925
577 2.6963
15,307 2.6983
1,800 2.7063
900 2.7071
500 2.7100
17,647 2.7120
972 2.7271
1,649 2.7285
5,386 2.7378
------------------------- -------------------- ------------------------- ------------------------- ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit (GBP) American, received per
option varying etc. option European unit
relates etc. (GBP)
-------------- ------------- ------------- ------------- ------------- ------------- ------------ -------------
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
(GBP)
----------------------- -------------------- ----------------------- --------------------- -----------------------
Ordinary Shares
----------------------- -------------------- ----------------------- --------------------- -----------------------
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable) (GBP)
e.g. subscription, conversion
--------------------------- ------------------------------- -------- -------------------------------------
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
----------------------------------------------------------------------------------------------
None
----------------------------------------------------------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt
principal trader making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
-----------------------------------------------------------------------------------------------
None
-----------------------------------------------------------------------------------------------
Date of disclosure: 20 November 2017
--------------------- ----------------------
Contact name: Evangelos Galiatsatos
--------------------- ----------------------
Telephone number: 020 7742 6148
--------------------- ----------------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FEROKKDKDBDDNDB
(END) Dow Jones Newswires
November 20, 2017 06:04 ET (11:04 GMT)
1 Year Spire Healthcare Chart |
1 Month Spire Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
